⏳ Fetching live dividend data...
Home › Calculator › AZYO Dividend Calculator 2026
Aziyo Biologics, Inc. · NASDAQ
Price: $1.49 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in AZYO → $13021520090644.00M in 10 years · $1,084,337,776,131,253,200.00/month
Aziyo Biologics, Inc. (AZYO) operates as a regenerative medicine firm, concentrating its efforts on developing advanced medical products. Their primary applications target three key areas: implantable electronic devices and cardiovascular care, orthopedic and spinal repair, and the reconstruction of soft tissues. The company's product portfolio includes CanGaroo, an innovative envelope that incorporates antibiotics, specifically engineered to lower the risk of infection following the surgical implantation of an electronic device. Aziyo also provides a suite of cardiovascular solutions. ProxiCor serves as an intracardiac patch or pledget for repairing heart tissues, while Tyke is designed for neonates and infants to mend pericardial structures. Additionally, VasCure offers a versatile patching material for the repair or reconstruction of peripheral blood vessels, encompassing critical arteries like the carotid, renal, iliac, femoral, and tibial, serving cardiovascular, vascular, and general surgeons. For orthopedic procedures, Aziyo offers human tissue-derived bone allografts such as Fiber VBM, ViBone, and OsteGro V. These products are formulated to protect and preserve the body's natural bone cells. In the realm of soft tissue repair, they feature SimpliDerm, a pre-hydrated human acellular dermal matrix (HADM) developed for the repair or replacement of damaged or insufficient skin and related integumental tissues. Beyond its proprietary product line, Aziyo Biologics extends contract manufacturing services, producing various items for other corporate clients. The company distributes its products to hospitals and other healthcare facilities through a multi-faceted sales approach, utilizing its dedicated direct sales force, strategic commercial partners, and independent sales agents. Founded in 2015, Aziyo Biologics, Inc. maintains its headquarters in Silver Spring, Maryland.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open AZYO position with:
Real after-tax yield depends on where you live and how you hold AZYO.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 134.23% | 131.43% | $13,423 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 114.10% | 111.30% | $11,410 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 107.38% | 104.58% | $10,738 / yr |
| 🇬🇧 UK ISA | 0% | 134.23% | 131.43% | $13,423 / yr |
| 🇬🇧 UK Taxable | 8.75% | 122.48% | 119.68% | $12,248 / yr |
| 🇨🇦 TFSA | 0% | 134.23% | 131.43% | $13,423 / yr |
| 🇨🇦 CA Taxable | 25% | 100.67% | 97.87% | $10,067 / yr |
| 🇦🇺 Super (pension) | 15% | 114.10% | 111.30% | $11,410 / yr |
| 🇦🇺 AU Taxable | 30% | 93.96% | 91.16% | $9,396 / yr |
| 🇩🇪 DE Taxable | 26.375% | 98.83% | 96.03% | $9,883 / yr |
| 🇫🇷 FR Taxable | 30% | 93.96% | 91.16% | $9,396 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
AZYO pays quarterly — 4 times per year. Next ex-div: TBD.
How AZYO compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for AZYO sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| J-Other | 2023-12-28 | 1,436,077 | $1.43 | $2.05M | ||
| J-Other | 2023-12-28 | 2,154,116 | $1.43 | $3.08M | ||
| J-Other | 2023-12-28 | 1,436,077 | $1.43 | $2.05M | ||
| J-Other | 2023-12-28 | 2,154,116 | $1.43 | $3.08M | ||
| Buy | 2021-09-21 | 2,837,128 | $1.43 | $4.05M | ||
| Buy | 2021-09-21 | 4,255,693 | $1.43 | $6.08M | ||
| Buy | 2021-09-21 | 2,837,128 | $1.43 | $4.05M | ||
| Buy | 2021-09-21 | 4,255,693 | $1.43 | $6.08M | ||
| Other | 2023-09-21 | 2,154,116 | $1.43 | $3.08M | ||
| A-Award | 2023-09-21 | 70,053 | $1.43 | $100.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the AZYO dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Aziyo Biologics, Inc. (AZYO) is currently trading at $1.49, trading near its 52-week low. The current dividend yield is 134.23% based on an annual payout of $2.00 per share.
Aziyo Biologics, Inc. (AZYO) is a healthcare stock currently trading at $1.49 with a dividend yield of 134.23%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →